MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Biocon
Biocon
BSE: 532523|NSE: BIOCON|ISIN: INE376G01013|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 21, 17:00
282.25
0.4 (0.14%)
VOLUME 31,906
LIVE
NSE
May 21, 17:00
282.60
0.7 (0.25%)
VOLUME 174,291
Management Interviews on Biocon
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Biocon, Mylan in deal for 3 bio-generic insulin drugs 

10.31 am | 14 Feb 2013 |  Source: CNBC-TV18

Biocon, a global biopharmaceutical enterprise today entered into a licencing agreement with Mylan for three bio-generic insulin products. Kiran Mazumd...

1
Quick Links for Biocon
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.